Sec Form 4 Filing - Institutional Venture Management XV, LLC @ Hims & Hers Health, Inc. - 2021-07-30

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Institutional Venture Management XV, LLC
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
2884 SAND HILL ROAD, SUITE 100
3. Date of Earliest Transaction (MM/DD/YY)
07/30/2021
(Street)
MENLO PARK, CA94025
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 07/30/2021 X( 1 ) 297 A $ 11.5 54,192 I Held by Institutional Venture Partners XV Executive Fund, L.P. ( 2 )
Class A Common Stock 07/30/2021 X( 1 ) 56,659 A $ 11.5 10,189,290 I Held by Institutional Venture Partners XV, L.P. ( 3 )
Class A Common Stock 07/30/2021 X( 1 ) 56,961 A $ 11.5 10,243,499 I Held by Institutional Venture Partners XVI, L.P. ( 4 )
Class A Common Stock 07/30/2021 S( 5 ) 218 D 53,974 I Held by Institutional Venture Partners XV Executive Fund, L.P. ( 2 )
Class A Common Stock 07/30/2021 S( 5 ) 41,532 D 10,147,758 I Held by Institutional Venture Partners XV, L.P. ( 3 )
Class A Common Stock 07/30/2021 S( 5 ) 41,753 D 10,201,746 I Held by Institutional Venture Partners XVI, L.P. ( 4 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant (right to buy) $ 11.5 07/30/2021 X 297 01/20/2021 01/20/2026 Class A Common Stock 297 $ 0 297 I Held by Institutional Venture Partners XV Executive Fund, L.P. ( 2 )
Warrant (right to buy) $ 11.5 07/30/2021 X 56,659 01/20/2021 01/20/2026 Class A Common Stock 56,659 $ 0 56,659 I Held by Institutional Venture Partners XV, L.P. ( 3 )
Warrant (right to buy) $ 11.5 07/30/2021 X 56,961 01/20/2021 01/20/2026 Class A Common Stock 56,961 $ 0 56,961 I Held by Institutional Venture Partners XVI, L.P. ( 4 )
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Institutional Venture Management XV, LLC
2884 SAND HILL ROAD, SUITE 100
MENLO PARK, CA94025
X
Institutional Venture Partners XV Executive Fund, L.P.
2884 SAND HILL ROAD, SUITE 100
MENLO PARK, CA94025
X
Institutional Venture Partners XV, L.P.
2884 SAND HILL ROAD, SUITE 100
MENLO PARK, CA94025
X
Institutional Venture Management XVI, LLC
2884 SAND HILL ROAD, SUITE 100
MENLO PARK, CA94025
X
Institutional Venture Partners XVI, L.P.
2884 SAND HILL ROAD, SUITE 100
MENLO PARK, CA94025
X
Chaffee Todd C
2884 SAND HILL ROAD, SUITE 100
MENLO PARK, CA94025
X
FOGELSONG NORMAN A
2884 SAND HILL ROAD, SUITE 100
MENLO PARK, CA94025
X
Harrick Stephen J
2884 SAND HILL ROAD, SUITE 100
MENLO PARK, CA94025
X
Phelps Dennis B
2884 SAND HILL ROAD, SUITE 100
MENLO PARK, CA94025
X
Miller J Sanford
2884 SAND HILL ROAD, SUITE 100
MENLO PARK, CA94025
X
Signatures
By: /s/ Tracy Hogan, attorney-in-fact 08/03/2021
Signature of Reporting Person Date
Explanation of Responses:
( 1 )IVP XV Executive Fund, IVP XV and IVP XVI (as defined below) exercised warrants to purchase shares of the Issuer's Class A Common Stock. The warrants were exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, IVP XV Executive Fund, IVP XV and IVP XVI received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised.
( 2 )These shares are owned directly by Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund"), of which Institutional Venture Management XV, LLC ("IVM XV") is the sole general partner and exercises voting and investment power over these shares. The managing directors of IVM XV are Todd C. Chaffee, Norman A. Fogelsong, Stephen J. Harrick, Dennis B. Phelps, Jr., J. Sanford Miller, Eric Liaw, Somesh Dash and Jules A. Maltz. The reporting persons disclaim beneficial ownership of these securities, except to the extent of their respective proportionate pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Mr. Maltz is a director of the Issuer and files separate Section 16 reports.
( 3 )These shares are owned directly by Institutional Venture Partners XV, L.P. ("IVP XV"), of which IVM XV is the sole general partner and exercises voting and investment power over these shares. The managing directors of IVM XV are Todd C. Chaffee, Norman A. Fogelsong, Stephen J. Harrick, Dennis B. Phelps, Jr., J. Sanford Miller, Eric Liaw, Somesh Dash and Jules A. Maltz. The reporting persons disclaim beneficial ownership of these securities, except to the extent of their respective proportionate pecuniary interest therein and this repo rt shall not be deemed an admission that any reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Mr. Maltz is a director of the Issuer and files separate Section 16 reports.
( 4 )These shares are owned directly by Institutional Venture Partners XVI, L.P. ("IVP XVI"), of which Institutional Venture Management XVI, LLC ("IVM XVI") is the sole general partner and exercises voting and investment power over these shares. The managing directors of IVM XVI are Todd C. Chaffee, Norman A. Fogelsong, Stephen J. Harrick, Dennis B. Phelps, Jr., J. Sanford Miller, Eric Liaw, Somesh Dash, and Jules A. Maltz. The reporting persons disclaim beneficial ownership of these securities, except to the extent of their respective proportionate pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Mr. Maltz is a director of the Issuer and files separate Section 16 reports.
( 5 )Represents shares of Class A Common Stock withheld in connection with the cashless exercises.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.